In DSS tumors, activin signaling genes (Acvr1b, Acvr2a, and Smad4) were highly mutated (Supplementary Data 2 and Fig. 2c), suggesting the involvement of activin signaling in inflammation-associated tumor development. This evidence concerns the gene ACVR1B and neoplasm.